XCL1 and atherosclerosis: Considering the vital role that Xcr1+ cDC1 plays in the progression of atherosclerosis and the therapeutic potential of manipulating their functions via chemokines (Yan et al., 2021), comprehending the feasibility of targeting Xcl1 holds considerable promise for developing novel therapeutic approaches to halt the advancement of atherosclerosis.